| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 01/26/2005 | CN1569034A Bone strengthening Chinese medicinal preparation for treating osteoporosis and its preparing method |
| 01/26/2005 | CN1569032A Cattle bone ash made burns treating medicine |
| 01/26/2005 | CN1569031A Plasma component series preparation by inactivating virus and sieving sectionally by hyperfiltration membrane |
| 01/26/2005 | CN1569030A Albumen removed extraction of calf blood for injection and its preparing process |
| 01/26/2005 | CN1569007A Amino acid liquor and its preparation method |
| 01/26/2005 | CN1568681A Method for cultivating toad evildoers using traditional Chinese medicine |
| 01/26/2005 | CN1186440C New bifidobacteria preventing diarrhea caused by pathogenic bacteria |
| 01/26/2005 | CN1186095C Usage of clostridium toxin or its compound in the preparation process of Therapeutic agent snoring noises suppressing agent |
| 01/26/2005 | CN1186088C Tiegudan for ischemic necrosis of fernoral head and its preparation |
| 01/26/2005 | CN1186085C Traditional Chinese medicine for treating deformed soft-tissue |
| 01/26/2005 | CN1186080C Laryngopharyngitis treating medicine |
| 01/26/2005 | CN1186075C Medicine for treating pulmonary tuberculosis |
| 01/26/2005 | CN1186074C Chinese patent drug for treating hemiplegia caused by apoplexy |
| 01/26/2005 | CN1186072C Health wine for expelling wind, clearing away cold and removing dampness |
| 01/26/2005 | CN1186068C Externally applied Chinese medicine with functions of diminishing inflammation, promoting granulation, stopping itch and stopping pain and its preparation process |
| 01/26/2005 | CN1186063C Medicine for treating diabetes and its complication |
| 01/26/2005 | CN1186057C Chinese medicinal pill for reinforcing kidney and strengthening yang, warming and recuperating qi and blood, and improving organism immunity |
| 01/26/2005 | CN1186056C Medicine for treating osteoproliferation |
| 01/26/2005 | CN1186053C Medicine for treating kidney disease and its preparation method |
| 01/26/2005 | CN1186050C Ointment for removing necrosis, promoting granulation and invigorating bone and its preparation |
| 01/26/2005 | CN1186047C Externally applied psoriasis treating medicine and its preparation |
| 01/26/2005 | CN1186043C Externally applied medicine for treating osteopathy and its preparation method |
| 01/26/2005 | CN1186041C Traditional Chinese medicinal wine for treating rheumatism and its preparing method |
| 01/26/2005 | CN1186040C Sight promoting agent |
| 01/26/2005 | CN1186039C Method for preparing Chinese medicine composition for treating ankylosing spondylitis complicated necrosis of femoral head |
| 01/26/2005 | CN1186038C Capsule for treating aplastic anemia and its production method |
| 01/26/2005 | CN1186037C Medicine for treating hepatitis |
| 01/26/2005 | CN1186035C Health food capsule with functions of sobering up, detoxicating, nourishing heart, tranquilizing and protecting liver and its production process |
| 01/26/2005 | CN1186032C Health-care food prepared from extracts of animals bone marrow and Chinese-medicinal materials |
| 01/26/2005 | CN1186029C Medicine for treating facial paralysis and its preparing process |
| 01/26/2005 | CN1186027C Cancer-treating Chinese medicine and its preparation method |
| 01/25/2005 | US6846676 In Vivo production and delivery of erythropoietin or insulinotropin for gene therapy |
| 01/25/2005 | US6846670 Expressing heterologous nucleotide sequences in cells; obtain vascular cells, incubate with herpes virus, monitor propagation of virus in central nervous system |
| 01/25/2005 | US6846667 Virulence genes and proteins, and their use |
| 01/25/2005 | US6846665 Method of producing a recombinant adeno-associated virus, suitable means for producing the same and use thereof for producing a medicament |
| 01/25/2005 | US6846490 Enhance hydrophobicity of a biological surface by applying vernix and a dispersant |
| 01/25/2005 | CA2436196A1 Oncolytic virus for purging cellular compositions of cells of lymphoid malignancies |
| 01/25/2005 | CA2435967A1 Reovirus for the treatment of lymphoid malignancies |
| 01/25/2005 | CA2146442C Anti-inflammatory factor, method of isolation, and use |
| 01/25/2005 | CA2133108C Pasteurella haemolytica type a-1 bacterin-toxoid vaccine |
| 01/25/2005 | CA2123224C Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes |
| 01/20/2005 | WO2005005637A2 Herpes simplex virus comprising a genetically modified glycoprotein d |
| 01/20/2005 | WO2005005622A2 Method of altering cell properties by administering rna |
| 01/20/2005 | WO2005005620A1 Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical proparations |
| 01/20/2005 | WO2005005609A2 Multi-staged absorbable nonwoven structures for culturing pancreatic cells |
| 01/20/2005 | WO2005005481A2 Combination therapy for gastroenteric diseases caused by microorganisms |
| 01/20/2005 | WO2005004990A1 Use of whey permeate for the treatment of metabolic syndrome |
| 01/20/2005 | WO2005004892A1 Plant worms mycelium extracat fraction and composition for oral intake |
| 01/20/2005 | WO2005004888A1 Lipids from methanotrophic bacteria for cholesterol reduction |
| 01/20/2005 | WO2005004887A1 Pharmaceutical agent against colon carcinoma and other tumor types |
| 01/20/2005 | WO2005004886A1 Isolation of bone marrow fraction rich in connective tissue growth components and the use thereof to promote connective tissue formation |
| 01/20/2005 | WO2004096126A3 Treating hepatocellular carcinomas using therapeutic viruses |
| 01/20/2005 | WO2004093846A3 Charged initiator polymers and methods of use |
| 01/20/2005 | WO2004089407A3 Zwitterionic immunomodulators for the treatment of asthma and allergy |
| 01/20/2005 | WO2004089386A8 Antiobestic agent using hen’s egg antibody against digestive enzymes |
| 01/20/2005 | WO2004089385A8 An ayurvedic nutritional preparation |
| 01/20/2005 | WO2004012791A3 Improved injection system |
| 01/20/2005 | WO2003102171A9 Expansion and transdifferentiation of human acinar cells |
| 01/20/2005 | WO2003082302A9 Bioadhesive directed somatic cell therapy |
| 01/20/2005 | US20050014930 Bactericide for mrsa |
| 01/20/2005 | US20050014738 Solid phase extraction; contacting with adsorption resin |
| 01/20/2005 | US20050014693 Transmission and, or amplification of signals; oral or enteric administering, dissolving, absorption of peptide yy; obesity therapy |
| 01/20/2005 | US20050014289 Stable compositions for measuring human natriuretic peptides |
| 01/20/2005 | US20050014262 Viral expression vector for use as heterologous gene and/or therapeutic protein delivery tools; genetic vaccine |
| 01/20/2005 | US20050014258 Methods for altering cell fate |
| 01/20/2005 | US20050014256 Stem cell and dental pulp harvesting method and apparatus |
| 01/20/2005 | US20050014255 Stem cells for clinical and commercial uses |
| 01/20/2005 | US20050014254 Progenitor cell tissue from exocrine gland for use in regenerative and transplantion medicine; tissue egineering; tissue targeted therapy |
| 01/20/2005 | US20050014252 Apparatus comprising biodegradable matrix for use in storage and transfer of viable cells to mammals; tissue engineering; regenerative medicine |
| 01/20/2005 | US20050013872 Maintenance, regeneration; medical equipment such as stent, artificial heart; insertion into body |
| 01/20/2005 | US20050013871 Pharmaceutical composition for the treatment of itch |
| 01/20/2005 | US20050013870 Decellularized extracellular matrix of conditioned body tissues and uses thereof |
| 01/20/2005 | US20050013831 Obtained from neisseria meningitidis and commensal neisseria; broad spectrum protective immunity |
| 01/20/2005 | US20050013830 Containing cordyceps sinensis or extract; suppressing decrease of spongy bone density |
| 01/20/2005 | US20050013829 Novel growth factor Opa1 and uses thereof |
| 01/20/2005 | US20050013824 Use of highly Immunodominant central nervous system myelin protein; inducing tolerance |
| 01/20/2005 | US20050013808 Nitroreductase enzymes |
| 01/20/2005 | US20050013807 In vitro cultured skin tissue; HIF-1 alpha activity, stable under normoxic conditions; rapid vascularization; burns, wounds |
| 01/20/2005 | US20050013803 Diagnosing and treating cancer cells using mutant viruses |
| 01/20/2005 | US20050013802 EB Matrix production from fetal tissue and its use for tissue repair |
| 01/20/2005 | US20050013791 Cytokine-inducing material and cytokine-inducing instrument |
| 01/20/2005 | DE10330243A1 Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von Arzneimitteln zur äusserlichen Behandlung der Neurodermitis Use of products derived from extremophilic bacteria osmolytes for the production of drugs for external treatment of atopic dermatitis |
| 01/20/2005 | DE10330216A1 Verwendung von Stammzellen aus Nabelschnurblut zur Verhinderung von Hirnschäden infolge Sauerstoffmangel und zur Neuroprotektion Use of stem cells from umbilical cord blood to prevent brain damage due to lack of oxygen and for neuroprotection |
| 01/20/2005 | DE10329847A1 Pharmazeutischer Wirkstoff gegen Prostatakarzinome A pharmaceutical agent against prostate cancer |
| 01/20/2005 | DE10327489A1 Composition with wound-healing properties obtained from pupae of Diptera, useful particularly for wounds that heal poorly, e.g. diabetic ulcers |
| 01/20/2005 | CA2541753A1 Combination therapy for gastroenteric diseases caused by microorganisms |
| 01/20/2005 | CA2532833A1 Use of whey permeate for the treatment of metabolic syndrome |
| 01/20/2005 | CA2531629A1 Medicinal composition containing nf-.kappa.b decoy for treating and preventing respiratory diseases and method of using the same |
| 01/20/2005 | CA2531627A1 Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical preparations |
| 01/20/2005 | CA2531623A1 Isolation of bone marrow fraction rich in connective tissue growth components and the use thereof to promote connective tissue formation |
| 01/20/2005 | CA2531242A1 Method of altering cell properties by administering rna |
| 01/19/2005 | EP1498479A2 Non-myeloablative tolerogenic treatment |
| 01/19/2005 | EP1498478A1 Method of forming pancreatic beta cells from mesenchymal cells |
| 01/19/2005 | EP1498392A2 Device and method for treating drinking water for topical detergent, cosmetic and/or therapeutic use |
| 01/19/2005 | EP1498136A2 Non-myeloablative tolerogenic treatment |
| 01/19/2005 | EP1498134A1 Helicobacter pylori adhesion inhibitor |
| 01/19/2005 | EP1498129A1 Use of adenoviruses mutated in the va genes for cancer treatment |
| 01/19/2005 | EP1498039A1 Vital cell preparations containing lactic acid bacterium as the active ingredient and lactic acid bacterium-containing foods |
| 01/19/2005 | EP1497460A1 Diagnostic and therapeutic use of ensadin-0138 gene and protein for neurodegenerative diseases |
| 01/19/2005 | EP1497440A2 Stable adenoviral vectors and methods for propagation thereof |